Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

NVO TEVA AGN FRX BRL Bitcoins Investing Macroaxis 15 
Benchmark  United States  NYSE  10,576   5.981 Index Moved Down -0.06%  

Processing. Please wait...

PCYC insider: Joseph Buggy


Joseph Buggy - PCYC Insider Profile

Executive Officer

Dr. Joseph J. Buggy Ph.D. is Vice President Research of Pharmacyclics Inc. since September 2007. From May 2006 to August 2007 Dr. Buggy served as Senior Director Research at Pharmacyclics. From November 2001 to April 2006 he served as Director Department of Biology at Celera Genomics a biotechnology company. From June 1996 to October 2001 he was a staff scientist at AXYS Pharmaceuticals Inc. a biotechnology company. Prior to that Dr. Buggy worked as a scientist at Bayer Corporationrationration in West Haven CT
Age: 46  Executive Since 2007  Ph.D    
Joseph Buggy EducationBuggy received a Ph.D. in Molecular, Cellular, and Developmental Biology from Indiana University and a B.S. degree in Microbiology from the University of Pittsburgh.

Management Efficency

The company has return on total asset (ROA) of 10.89 % which means that it generated profit of $10.89 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 15.06 % meaning that it created $15.06 on every $100 dollars invested by stockholders.

PCYC price boundaries

April 11 2014
Lowest period price (30 days)
March 25 2014
Highest period price (30 days)

Entity Summary

Pharmacyclics, Inc., a biopharmaceutical company, designs, develops, and commercializes smallmolecule drugs for the treatment of cancer and immune mediated diseases in the United States and internationally. Pharmacyclics Inc [PCYC] is traded on NASDAQ in USA. It is located in Sunnyvale, CA and employs 484 people.

Filter other executives

Specify Title
Indicate Tenure
Select Industry
Click to run this filter
 Run Equity Filter
Filter Other Insiders
Showing first 15 of many records found


Ben-Zion WeinerTeva Pharmaceutical Industries
Kasper PoulsenNovo Nordisk AS
Abhijit (Chem)Dr Reddys Laboratories Ltd
Michael PerfettoTaro Pharmaceutical Industries
Sandeep PoddarDr Reddys Laboratories Ltd
Abhijeet (Chem)Dr Reddys Laboratories Ltd
Jayesh ShahTaro Pharmaceutical Industries
G LandisLannett Company Inc
Julian SternDepoMed Inc
Milan KalawadiaDr Reddys Laboratories Ltd
, MBCHB,MDTeva Pharmaceutical Industries
Ron GrupelTeva Pharmaceutical Industries
Kedar UpadhyeDr Reddys Laboratories Ltd
Jim HindmanAllergan Inc
Esq JDAllergan Inc
Pharmacyclics Inc
USA Stock
Currency: USD - US Dollar
Traded on NASDAQ

Fix Your Portfolios with PCYC

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Pharmacyclics Inc to your portfolio

Promote PCYC and Joseph Buggy

Follow PCYC with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker

Pharmacyclics Leadership

Lori MD, Executive
Jesse McGreivy, President, MBA
Richard CFA, Chairman
Gregory Hemmi, President, Ph.D
Darrin Beaupre, President
Kenneth Clark, Director
Rainer Erdtmann, SVP
Paula Boultbee, President
Minesh Mehta, Director, Ph.D
Robert Duggan, Chairman
Richard Love, President
Mark Asbury, President
Urte Gayko, President
David Smith, Director
Mahkam DDS, COO
Joshua Brumm, EVP
Christophe Suchet, President
Kenneth Boehm, President, MBA
Fong Clow, President
Cynthia Anderson, President
Christine Huh, President
Lori Kunkel, Executive
Robert Booth, Director, Ph.D
Scott Shearer, President, Ph.D
Heow Tan, Executive, MBA
David Loury, Executive, Ph.D
Rick Love, President
R Broek, Director
Eric Halvorson, Director
Sumita Ray, Executive
Manmeet Soni, CFO
Elizabeth Faust, President, Ph.D
Roy Hardiman, Director
Dana Lee, President
Richard Broek, Director
Maria Fardis, President, MBA
Michael Crum, President
Mahkam Zanganeh, Executive, MBA
Thorsten Graef, President
Betty Chang, President
Joseph Buggy, Executive, Ph.D
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Find Alpha
Equity Screener
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals, sectors and families
Research Equities
Insiders Screener
Find insiders across different sectors to evaluate their impact on performance and growth of their entities
Research Insiders

Stock Performance

Shares Outstanding74.79 M
Number of Shares Shorted1.48 M